Lansoprazole

Overview

Lansoprazole is a proton pump inhibitor which reduces stomach acid production. It is used primarily in the treatment of gastric ulcers and gastroesophageal reflux disease (GERD).

API suppliers (40)

Suppliers of Lansoprazole backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• TAPI NL BV1 active DMF
• MOEHS IBERICA SLSpain1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• ATABAY KIMYA SANAYI VE TICARET AS1 active DMF
• MATRIX PHARMACORP PRIVATE LTD1 active DMF
• UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain1 active DMF
• MOEHS IBERICA SLSpain1 active DMF
• Alkem Laboratories LimitedIndia1 active DMF
• MATRIX PHARMACORP PRIVATE LTD1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• Hetero Drugs LimitedIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Wockhardt LimitedIndia1 active DMF
• JUBILANT PHARMOVA LTD1 active DMF
• TAPI NL BV1 active DMF
• UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain1 active DMF
• MOEHS IBERICA SLSpain1 active DMF
• MATRIX PHARMACORP PRIVATE LTD1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• Hetero Drugs LimitedIndia1 active DMF
• Wockhardt LimitedIndia1 active DMF
• JUBILANT PHARMOVA LTD1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Natco PharmaIndia1 active DMF
• ATABAY KIMYA SANAYI VE TICARET AS1 active DMF

Showing 25 of 40 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (41 approved US products), the latest listed US patent on Lansoprazole expires 20 Apr 2036. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole

Canonical SMILES

CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F

InChIKey

MJIHNNLFOKEZEW-UHFFFAOYSA-N

Therapeutic areas